Connect with us

Business

What happened to the CSL (ASX:CSL) share price in 2020?

Published

on

It has been a bit of a mixed year for the CSL Limited (ASX: CSL) share price in 2020.

Although the biotherapeutics giant’s shares are on the cusp of recording a gain of almost 5% for the year, it could have been so much more.

Prior to the pandemic, the CSL share price was up almost 25% year to date. But since then, the company’s shares have gradually given back the majority of these gains.

What happened in 2020?

CSL has actually had a very positive year all things considered.

In FY 2020, the company delivered a strong result and looks set to build on this in the current financial year.

For example, for the 12 months ended 30 June 2020, CSL delivered a 7.2% increase in reported sales revenue to US$8,797 million. This was…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending